←Back to Expert Scholars
Translational Medicine / 转化医学Milestone IO Approvals
Caroline Robert
MD, PhD
🏢Institut Gustave Roussy🌐France
Head of Dermato-Oncology
130
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Caroline Robert led major pembrolizumab melanoma trials including KEYNOTE-006 in the metastatic setting and KEYNOTE-054 in adjuvant stage III melanoma. She heads dermato-oncology at Institut Gustave Roussy. Her work has shaped the global approval trajectory of pembrolizumab in melanoma.
Share:
🧪Research Fields 研究领域
pembrolizumab melanoma KEYNOTE-006
adjuvant IO melanoma KEYNOTE-054
French melanoma cohorts
checkpoint toxicity
long term IO
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Caroline Robert 的研究动态
Follow Caroline Robert's research updates
留下邮箱，当我们发布与 Caroline Robert（Institut Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment